APKPHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
APKPHARMA
Largest movements
- Financial fixed assets +€98,285
up €98,285 (+12.1%), from €810,000 to €908,285
- Receivables within one year +€73,680
up €73,680 (+151.8%), from €48,530 to €122,210
- Cash +€12,612
up €12,612 (+247.9%), from €5,088 to €17,700
mainly Net result for the year (+€83,345) and Current portion of long-term debt (+€78,335)
- Profit (loss) carried forward +€83,345
up €83,345 (+313.9%), from €26,555 to €109,899
- Current portion of long-term debt +€78,335
new in 2025: €78,335
- Tax, wage and social debts +€50,159
up €50,159 (+371.0%), from €13,519 to €63,678
- Debts after one year -€35,026
down €35,026 (-4.9%), from €720,000 to €684,974
- Gross operating margin +€96,674
up €96,674 (+181.9%), from €53,137 to €149,811
- Financial charges +€27,576
up €27,576 (+919193.3%), from €3 to €27,579
- Taxes +€18,900
up €18,900 (+160.2%), from €11,800 to €30,700
- Depreciation -€5,574
down €5,574 (-41.3%), from €13,501 to €7,927
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €874,724 | €1,051,542 | +€176,818 | +20.2% |
| Fixed assets | 21/28 | €820,280 | €910,638 | +€90,358 | +11.0% |
| Tangible fixed assets | 22/27 | €10,280 | €2,353 | -€7,927 | -77.1% |
| Furniture and vehicles | 24 | €10,280 | €2,353 | -€7,927 | -77.1% |
| Financial fixed assets | 28 | €810,000 | €908,285 | +€98,285 | +12.1% |
| Current assets | 29/58 | €54,444 | €140,904 | +€86,460 | +158.8% |
| Amounts receivable within one year | 40/41 | €48,530 | €122,210 | +€73,680 | +151.8% |
| Trade receivables | 40 | €48,530 | €122,210 | +€73,680 | +151.8% |
| Cash at bank and in hand | 54/58 | €5,088 | €17,700 | +€12,612 | +247.9% |
| Deferred charges and accrued income | 490/1 | €826 | €995 | +€168 | +20.3% |
| Total equity and liabilities | 10/49 | €874,724 | €1,051,542 | +€176,818 | +20.2% |
| Equity | 10/15 | €29,555 | €112,899 | +€83,345 | +282.0% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €26,555 | €109,899 | +€83,345 | +313.9% |
| Amounts payable | 17/49 | €845,170 | €938,643 | +€93,473 | +11.1% |
| Amounts payable after more than one year | 17 | €720,000 | €684,974 | -€35,026 | -4.9% |
| Financial debts | 170/4 | €720,000 | €684,974 | -€35,026 | -4.9% |
| Amounts payable within one year | 42/48 | €125,170 | €253,668 | +€128,499 | +102.7% |
| Current portion of amounts payable after more than one year | 42 | - | €78,335 | +€78,335 | |
| Trade debts | 44 | €14,749 | €10,106 | -€4,643 | -31.5% |
| Suppliers | 440/4 | €14,749 | €10,106 | -€4,643 | -31.5% |
| Taxes, remuneration and social security | 45 | €13,519 | €63,678 | +€50,159 | +371.0% |
| Taxes | 450/3 | €13,519 | €63,678 | +€50,159 | +371.0% |
| Other amounts payable | 47/48 | €96,902 | €101,550 | +€4,648 | +4.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €13,501 | €7,927 | -€5,574 | -41.3% |
| Other operating charges | 640/8 | €1,279 | €932 | -€347 | -27.2% |
| Gross operating margin | 9900 | €53,137 | €149,811 | +€96,674 | +181.9% |
| Operating profit (loss) | 9901 | €38,357 | €140,952 | +€102,595 | +267.5% |
| Financial income | 75/76B | €1 | €672 | +€671 | +103215.4% |
| Recurring financial income | 75 | €1 | €672 | +€671 | +103215.4% |
| Financial charges | 65/66B | €3 | €27,579 | +€27,576 | +919193.3% |
| Recurring financial charges | 65 | €3 | €27,579 | +€27,576 | +919193.3% |
| Profit (loss) for the period before taxes | 9903 | €38,355 | €114,045 | +€75,690 | +197.3% |
| Income taxes | 67/77 | €11,800 | €30,700 | +€18,900 | +160.2% |
| Profit (loss) for the period | 9904 | €26,555 | €83,345 | +€56,790 | +213.9% |
| Profit (loss) for the period to be appropriated | 9905 | €26,555 | €83,345 | +€56,790 | +213.9% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 9 October 2026 via checked.be.